The U.S. Preventive Services Task Force moved to ratify recommendations making high-risk HPV primary screening every five years the preferred cervical cancer screening method for women ages 30 to 65. [1][2]
For women ages 21 to 29, the task force kept its standing recommendation: cervical cytology alone every three years. [2]
Women ages 30 to 65 have two alternatives to HPV primary screening under the guidance — cytology alone every three years, or co-testing that combines HPV testing with cytology every five years. [2]
The panel’s recommendations carry direct financial weight. USPSTF determinations dictate which cancer screenings, counseling services and preventive medications insurers must cover at no cost to patients. [1]
Cervical cancer screening was one item on a full agenda. Members also planned to ratify final recommendations on screening and behavioral counseling to prevent unhealthy alcohol use in adolescents and adults, and interventions to prevent perinatal depression. [1]
Task force Chair Dr. Seth J. Corey described the panel’s purpose. “Our goal is really to meet, go over the evidence-based medicine with the goal of improving the lifespans and the quality of lives of all Americans,” Corey said. [1]



